As geopolitical tensions between the U.S. and Iran continue to impact Gulf markets, with key indices experiencing slight downturns due to disruptions in oil supply routes, investors are keeping a ...

Nectero Therapeutics, a clinical-stage biotechnology company developing therapies for aneurysmal disease, released two-year outcomes data today from the company’s first-in-human (FIH) trial of their ...